Cargando…
A significant response to sunitinib in a patient with anaplastic thyroid carcinoma
Anaplastic thyroid cancer (ATC) is a rare disease with an incidence of less than three cases per million of habitants in western countries. ATC accounts for 1-10% of all tumors derived from the thyroid gland. Classic chemotherapy approach based on platinum and anthracyclines regimens have been consi...
Autores principales: | Grande, Enrique, Capdevila, Jaume, Díez, Juan José, Longo, Federico, Carrato, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897033/ https://www.ncbi.nlm.nih.gov/pubmed/24516498 |
Ejemplares similares
-
Thyroid Cancer: Molecular Aspects and New Therapeutic Strategies
por: Grande, Enrique, et al.
Publicado: (2012) -
PD-1 Blockade in Anaplastic Thyroid Carcinoma
por: Capdevila, Jaume, et al.
Publicado: (2020) -
Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib
por: Jiménez-Fonseca, Paula, et al.
Publicado: (2018) -
Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012) -
Anaplastic Thyroid Carcinoma: An Update
por: Jannin, Arnaud, et al.
Publicado: (2022)